Cargando…
The regulatory pathways leading to stem-like cells underlie prostate cancer progression
Prostate cancer (PCa) is the most common cause of malignancy in males and the third leading cause of cancer mortality in the United States. The standard care for primary PCa with local invasive disease mainly is surgery and radiation. For patients with distant metastases, androgen deprivation therap...
Autores principales: | Lin, Chun-Jung, Lo, U-Ging, Hsieh, Jer-Tsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498735/ https://www.ncbi.nlm.nih.gov/pubmed/30178777 http://dx.doi.org/10.4103/aja.aja_72_18 |
Ejemplares similares
-
The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013) -
The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges
por: Yun, Eun-Jin, et al.
Publicado: (2016) -
The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017) -
The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022) -
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways
por: Chen, Yu-An, et al.
Publicado: (2018)